Illumina Inc. cut its full-year adjusted profit guidance for the second time in three months as it grapples with the impact ...

The latest move by China also comes a month after Illumina was placed on the country’s “unreliable entities list” immediately following Trump’s first round of tariff threats against China ...

Illumina faces significant challenges, including revenue declines, margin pressures, and geopolitical hurdles. Read how ILMN ...

Illumina lowered its full-year outlook as a result of increased costs tied to tariffs. The maker of gene-sequencing equipment and services said Thursday it anticipates $85 million in tariff related ...

In February, Illumina announced it would be laying off 96 San Diego workers.

Good day, ladies and gentlemen, and welcome to the first-quarter 2025 Illumina earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded. I would ...

The DNA sequencing company also cut its 2025 earnings outlook to reflect the impact of tariffs on its business.

Now Beijing is going further. Retaliating against the White House’s latest 10% tariff on all Chinese imports, China's government said Illumina will be barred from exporting gene sequencers to China.

Illumina Inc (ILMN) reports strong cash flow and innovation pipeline amidst macroeconomic pressures and revised guidance.

research revenue growth and mitigation strategies for China-related risks. CEO Thaysen emphasized resilience in Illumina's core business and measures to fully compensate for potential China ...